FDA — authorised 4 January 1960
- Application: NDA012041
- Marketing authorisation holder: APOTHECON
- Status: supplemented
FDA authorised Kenalog on 4 January 1960
Yes. FDA authorised it on 4 January 1960; FDA authorised it on 4 March 1960; FDA authorised it on 1 February 1965.
APOTHECON holds the US marketing authorisation.